Literature DB >> 2650836

Epidemic of nosocomial Legionnaires' disease in renal transplant recipients: a case-control and environmental study.

N M Le Saux1, L Sekla, J McLeod, S Parker, D Rush, J R Jeffery, R C Brunham.   

Abstract

An outbreak of Legionella pneumophila pneumonia occurred in 6 of 49 new renal transplant recipients over the course of 13 months. We compared infected patients (cases) and uninfected patients (controls) with respect to potential risk factors. Corticosteroid use, need for hemodialysis and number of days of hemodialysis were significantly greater among the cases. Logistic regression analysis identified corticosteroid dosage and number of days of hemodialysis as independent risk factors. Lymphopenia and monocytopenia were correlated with the amount of corticosteroid administered and occurred to a greater degree in the cases. All clinical isolates were of L. pneumophila serogroup 1, subtype Philadelphia 1, which was also cultured from a recovery room sink outside the operating room where the transplants were done. Other areas of the hospital were colonized with other, heterogeneous strains of L. pneumophila. The organism was not eliminated from the hospital water supply despite shock chlorination and superheating of water tanks. The epidemic ended when new transplant recipients routinely received prophylactic trimethoprim-sulfamethoxazole (160-800 mg given orally once daily) while in hospital after transplantation. Corticosteroid-induced monocytopenia and lymphopenia and the complement activation and monocyte depletion effects of hemodialysis may combine to increase susceptibility to Legionnaires' disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650836      PMCID: PMC1268977     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  32 in total

1.  Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains.

Authors:  E Dournon; W F Bibb; P Rajagopalan; N Desplaces; R M McKinney
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

2.  Legionnaires' disease in renal-transplant recipients.

Authors:  B V Bock; B D Kirby; P H Edelstein; W L George; K M Snyder; M L Owens; C M Hatayama; C E Haley; R P Lewis; R D Meyer; S M Finegold
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

3.  In vitro susceptibility of Legionella pneumophila, serogroups I-IV.

Authors:  L D Saravolatz; D J Pohlod; E L Quinn
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

4.  Legionnaires' disease in patients with associated serious disease.

Authors:  D W Gump; R O Frank; W C Winn; R S Foster; C V Broome; W B Cherry
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

5.  Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center.

Authors:  C E Haley; M L Cohen; J Halter; R D Meyer
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

6.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

7.  Suppression of human cytotoxic lymphocytes by methylprednisolone. An immunosuppressive mechanism of action of steroids.

Authors:  J C Rosenberg; K Lysz
Journal:  Transplantation       Date:  1978-03       Impact factor: 4.939

8.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

9.  Sporadic legionellosis in the United States: the first thousand cases.

Authors:  A C England; D W Fraser; B D Plikaytis; T F Tsai; G Storch; C V Broome
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

10.  Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.

Authors:  Z Werb
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  7 in total

1.  Control of endemic nosocomial legionnaires' disease by using sterile potable water for high risk patients.

Authors:  T J Marrie; D Haldane; S MacDonald; K Clarke; C Fanning; S Le Fort-Jost; G Bezanson; J Joly
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Molecular epidemiology of Legionella pneumophila infection at a Canadian tertiary care institution.

Authors:  L Nicolle; H Bialkowska-Hobrzanska; B Dyck; L Sekla; S Parker
Journal:  Can J Infect Dis       Date:  1994-07

4.  Legionella-associated lung abscess: Critical pathogen or minor isolate?

Authors:  G C Dow; A W Chow
Journal:  Can J Infect Dis       Date:  1992-11

5.  Diverse populations of Legionella pneumophila present in the water of geographically clustered institutions served by the same water reservoir.

Authors:  G Bezanson; S Burbridge; D Haldane; C Yoell; T Marrie
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

6.  Nosocomial legionellosis in three heart-lung transplant patients: case reports and environmental observations.

Authors:  J M Bangsborg; S Uldum; J S Jensen; B G Bruun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

7.  Legionella pneumophila monoclonal antibody subgroups and DNA sequence types isolated in Canada between 1981 and 2009: Laboratory Component of National Surveillance.

Authors:  A R Reimer; S Au; S Schindle; K A Bernard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-04       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.